We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
+10.6%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$6.61B
AUM Growth
+$398M
Cap. Flow
-$226M
Cap. Flow %
-3.42%
Top 10 Hldgs %
15.55%
Holding
1,373
New
121
Increased
405
Reduced
579
Closed
55

Top Buys

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$17.2M
2
AEGR
Aegerion Pharmaceuticals
AEGR
+$14M
3
PEP icon
PepsiCo
PEP
+$12.7M
4
AAPL icon
Apple
AAPL
+$11.7M
5
GE icon
GE Aerospace
GE
+$9.75M

Top Sells

Rank Stock Value
1
FLS icon
Flowserve
FLS
+$13.3M
2
XYL icon
Xylem
XYL
+$13M
3
MSFT icon
Microsoft
MSFT
+$12.4M
4
WWAV
The WhiteWave Foods Company
WWAV
+$12.2M
5
SPXC icon
SPX Corp
SPXC
+$12M

Sector Composition

Rank Sector Weight
1 Healthcare 15.88%
2 Technology 13.2%
3 Industrials 12.57%
4 Financials 12.22%
5 Consumer Staples 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOG icon
1
Alphabet (Google) Class C
GOOG
$3.9T
$141M 2.13%
5,052,186
-271,253
-5% -$6.86M
AAPL icon
2
Apple
AAPL
$4.89T
$140M 2.11%
6,962,788
+616,924
+10% +$11.7M
GE icon
3
GE Aerospace
GE
$367B
$123M 1.86%
917,169
+77,382
+9% +$9.75M
MSFT icon
4
Microsoft
MSFT
$2.84T
$102M 1.54%
2,721,888
-342,015
-11% -$12.4M
XOM icon
5
ExxonMobil
XOM
$651B
$100M 1.51%
988,067
+14,946
+2% +$1.38M
PFE icon
6
Pfizer
PFE
$140B
$95.2M 1.44%
3,277,226
+52,136
+2% +$1.52M
JNJ icon
7
Johnson & Johnson
JNJ
$634B
$89.7M 1.36%
978,835
+41,270
+4% +$3.8M
JPM icon
8
JPMorgan Chase
JPM
$939B
$86.3M 1.31%
1,475,824
+148,667
+11% +$8.14M
GILD icon
9
Gilead Sciences
GILD
$161B
$83.9M 1.27%
1,117,771
+47,956
+4% +$3.34M
CVX icon
10
Chevron
CVX
$388B
$67M 1.01%
536,515
+11,808
+2% +$1.43M
IBM icon
11
IBM
IBM
$202B
$64M 0.97%
356,877
+6,866
+2% +$1.18M
MRK icon
12
Merck
MRK
$324B
$56.7M 0.86%
1,187,703
+136,341
+13% +$6.23M
INTC icon
13
Intel
INTC
$464B
$55.9M 0.85%
2,152,389
-36,612
-2% -$886K
PEP icon
14
PepsiCo
PEP
$186B
$54M 0.82%
651,204
+152,667
+31% +$12.7M
BKNG icon
15
Booking.com
BKNG
$138B
$48.9M 0.74%
1,050,775
-114,025
-10% -$5.07M
CELG
16
DELISTED
Celgene Corp
CELG
$46.6M 0.7%
551,396
-1,730
-0.3% -$137K
PG icon
17
Procter & Gamble
PG
$343B
$44.1M 0.67%
541,415
-42,235
-7% -$3.44M
COP icon
18
ConocoPhillips
COP
$147B
$42M 0.64%
594,727
+5,610
+1% +$403K
PM icon
19
Philip Morris
PM
$301B
$41.9M 0.63%
481,450
-87,587
-15% -$7.65M
BAC icon
20
Bank of America
BAC
$435B
$41.9M 0.63%
2,693,563
+38,810
+1% +$576K
HON icon
21
Honeywell
HON
$77B
$41.5M 0.63%
504,974
+69,523
+16% +$5.43M
UNH icon
22
UnitedHealth
UNH
$382B
$41.1M 0.62%
546,389
+29,089
+6% +$2.09M
KO icon
23
Coca-Cola
KO
$354B
$40.2M 0.61%
972,915
+67,818
+7% +$2.67M
ORCL icon
24
Oracle
ORCL
$331B
$39.6M 0.6%
1,034,765
-60,154
-5% -$2.07M
T icon
25
AT&T
T
$165B
$39.6M 0.6%
1,490,259
+186,483
+14% +$4.91M
1
2 3 4 5

Similar funds

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking Tokyo, Japan $40.6B AUM 25.18% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

KBC Group's Q4 2013 Portfolio in Review

As of Q4 2013, KBC Group held 1,373 positions worth $6.61B, up 6.4% from $6.21B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

KBC Group withdrew a net $226M in Q4 2013, closing 55 positions and reducing 579 holdings. Its most notable exit was Steris, an estimated $5.72M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

Against the trend, KBC Group opened a new position in Aegerion Pharmaceuticals worth $13M.

  • KBC Group's largest Q4 2013 buy was Aegerion Pharmaceuticals: 183,492 shares worth $13M.
  • KBC Group added most to EOG Resources in Q4 2013, an estimated $17.2M increase.
  • KBC Group's biggest Q4 2013 reduction was Flowserve, cutting an estimated $13.3M.
  • KBC Group fully exited Steris in Q4 2013, selling an estimated $5.72M.
  • KBC Group's ten largest holdings make up 16% of its $6.61B portfolio in Q4 2013.
  • KBC Group opened 121 new positions and closed 55 in Q4 2013.
  • KBC Group's portfolio value rose 6.4% quarter-over-quarter to $6.61B.

Based on KBC Group's 13F filing for Q4 2013, filed 21 Jan 2014.